OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.435
+0.035 (2.50%)
May 6, 2026, 1:56 PM EDT - Market open
OmniAb Market Cap
OmniAb has a market cap or net worth of $207.76 million as of May 6, 2026. Its market cap has decreased by -7.04% in one year.
Market Cap
207.76M
Enterprise Value
169.00M
1-Year Change
-7.04%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $207.76M, a decrease of -79.08%. That is a compound annual growth rate of -35.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 202.70M | -23.89% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 210.30M |
| Nkarta | 208.88M |
| Context Therapeutics | 208.57M |
| Atrium Therapeutics | 208.37M |
| Replimune Group | 206.43M |
| MacroGenics | 198.94M |
| Elicio Therapeutics | 197.76M |
| Karyopharm Therapeutics | 197.70M |